Shijiazhuang Yiling Pharmaceutical Co., Ltd., commonly referred to as Yiling Pharmaceutical, is a leading player in the Chinese pharmaceutical industry, headquartered in Shijiazhuang, CN. Established in 1992, the company has made significant strides in the development and production of traditional Chinese medicine and modern pharmaceuticals, focusing on areas such as cardiovascular health, oncology, and respiratory diseases. Yiling Pharmaceutical is renowned for its innovative core products, including the widely acclaimed Yiling Qingfei Paidu Decoction, which exemplifies the integration of traditional practices with contemporary science. With a strong commitment to research and development, the company has achieved notable milestones, positioning itself as a trusted name in both domestic and international markets. Its dedication to quality and efficacy has earned Yiling Pharmaceutical a prominent market position, making it a key contributor to the advancement of healthcare solutions.
How does Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s score of 22 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shijiazhuang Yiling Pharmaceutical Co., Ltd., headquartered in CN, currently does not have available emissions data for the most recent year. As a result, specific figures regarding their carbon emissions, including Scope 1, 2, and 3 totals, are not provided. The company has not outlined any reduction targets or commitments related to climate initiatives, indicating a lack of formalised strategies in this area. Furthermore, there are no emissions data cascaded from a parent or related organisation, suggesting that Shijiazhuang Yiling Pharmaceutical operates independently in terms of climate reporting. In the absence of specific emissions data and reduction commitments, it is essential for Shijiazhuang Yiling Pharmaceutical to consider establishing measurable climate goals and reporting frameworks to enhance transparency and accountability in their environmental impact.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shijiazhuang Yiling Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

